Heinen Charlotte A, Zwaveling-Soonawala Nitash, Fliers Eric, Turgeon Marc-Olivier, Bernard Daniel J, van Trotsenburg A S Paul
Department of Pediatric Endocrinology, Emma Children's Hospital, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Department of Endocrinology and Metabolism, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
J Endocr Soc. 2017 May 2;1(6):731-736. doi: 10.1210/js.2017-00107. eCollection 2017 Jun 1.
IGSF1 deficiency is a recently discovered syndrome consisting of congenital central hypothyroidism (CeH) and macroorchidism. Here, we report on a patient presenting with short stature, who was found to carry a pathogenic mutation in the gene.
A 14-year-old Israeli boy was referred to the Academic Medical Center in Amsterdam, The Netherlands, for follow-up on short stature ascribed to constitutional delay of growth and puberty, and familial hypercholesterolemia. Primary hypothyroidism had previously been excluded by a normal thyroid-stimulating hormone (TSH) concentration. However, in follow-up, plasma free thyroxine (FT4) concentrations were repeatedly low, and the patient was diagnosed with CeH. Because of coexistent relative macroorchidism, gene analysis was performed, revealing a mutation (c.2588C>G; p.Ser863Cys). The mutant IGSF1 protein was retained mainly in the endoplasmic reticulum and reached the plasma membrane with poor efficiency compared with wild-type protein. After starting thyroxine treatment, plasma cholesterol almost normalized.
This case illustrates the necessity of measuring both FT4 and TSH when hypothyroidism is suspected, or needs to be ruled out. In addition, this case suggests that the presence of childhood hypercholesterolemia may be an indication of undiagnosed hypothyroidism.
IGSF1缺乏症是一种最近发现的综合征,由先天性中枢性甲状腺功能减退症(CeH)和巨睾症组成。在此,我们报告一名身材矮小的患者,该患者被发现该基因存在致病性突变。
一名14岁的以色列男孩被转诊至荷兰阿姆斯特丹的学术医疗中心,以随访因体质性生长和青春期延迟以及家族性高胆固醇血症导致的身材矮小。此前通过正常的促甲状腺激素(TSH)浓度排除了原发性甲状腺功能减退症。然而,在随访中,血浆游离甲状腺素(FT4)浓度反复偏低,该患者被诊断为CeH。由于同时存在相对巨睾症,进行了基因分析,发现一个突变(c.2588C>G;p.Ser863Cys)。与野生型蛋白相比,突变的IGSF1蛋白主要保留在内质网中,到达质膜的效率较低。开始甲状腺素治疗后,血浆胆固醇几乎恢复正常。
该病例说明了在怀疑或需要排除甲状腺功能减退症时同时测量FT4和TSH的必要性。此外,该病例表明儿童高胆固醇血症的存在可能是未诊断出的甲状腺功能减退症的一个指征。